News

Gritgen Therapeutics Co., a biotechnology company focused on gene therapy products, reported the successful validation and launch of operations at its commercial GMP facility in Suzhou China for the production of Gritgen's phase III clinical and commercial product for...

Cellipont Bioservices has signed an agreement with Diakonos Oncology for the development of DOC1021, a cell therapy to treat glioblastoma multiforme (GBM). The parties will carry out the process development and current good manufacturing practice (cGMP) production of DOC1021 for...

Cryoport, Inc. , a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences, and the Cell and Gene Therapy Catapult,...

Cold Chain Technologies, LLC, a leading provider of thermal packaging solutions for the transportation of temperature-sensitive products for the life sciences industry, announced it has acquired Exeltainer, a global provider of life sciences thermal packaging solutions with manufacturing hubs...

Phastar, a global specialist biometrics contract research organization (CRO), has had its net-zero target approved by the Science Based Targets initiative (SBTi). The SBTi is a global body enabling businesses to set ambitious emissions reductions targets in line with...

All drug manufacturers responsible for manufacturing the 10 prescription medicines that will be subject to the inaugural price negotiations for the U.S. Medicare health programme, such as Amgen as well as Novartis, have confirmed their participation in the talks by the...

Hear us out, everyone: technology addiction is real. It’s true that technology improves communication and enhances efficiency and productivity, but its overuse could be dangerous. Increasing digitalization has been linked with depression and anxiety. Researchers noticed a sudden increase in...